Bio-Rad launches rapid drugs screening test:
This article was originally published in Clinica
Bio-Rad is introducing its TOX/see hand-held toxicology screening device for drugs of abuse, which offers results in three minutes. The FDA-cleared urine sample immunoassay test will be marketed worldwide to hospitals and laboratories as an alternative to automated toxicology tests where volumes are small. The Hercules, California-based company says that the system provides an economical alternative to products already on the market.
You may also be interested in...
The International Generic and Biosimilar Medicines Association has urged the World Intellectual Property Organization to withdraw its support for a global database of pharmaceutical patent information. The Pat-INFORMED database – which is comprised of intellectual-property information provided by originators – contains unverified data and lacks appropriate safeguards, the IGBA contends.
Reforms to the US 180-day exclusivity incentive included in the Blocking Act that is part of the Lower Health Care Costs Act could cost the US healthcare system approximately $1.7bn, the AAM has warned.